Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America-Reference-Cited by-同舟云学术

Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America

Published:2011-11 Issue:11 Volume:6 Page:1955-1959
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Arrieta Oscar,Cardona Andrés Felipe,Federico Bramuglia Guillermo,Gallo Aly,Campos-Parra Alma D.,Serrano Silvia,Castro Marcelo,Avilés Alejandro,Amorin Edgar,Kirchuk Ricardo,Cuello Mauricio,Borbolla José,Riemersma Omar,Becerra Henry,Rosell Rafael

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference16 articles.

1. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat Rev Cancer,2005

2. EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc Natl Acad Sci USA,2004

3. Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation;Suda;Cancer Metastasis Rev,2010

4. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib;Pao;PLoS Med,2005

5. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung Cancer Clinical Trials in Latin America in the Era of Cooperative Groups: A 20-Year Analysis;JCO Global Oncology;2024-04

2. Implementing precision oncology in Latin America to improve patient outcomes: the status quo and a call to action for key stakeholders and decision-makers;ecancermedicalscience;2024-01-08

3. Cost-Effectiveness of Comprehensive Genomic Profiling in Patients With Non–Small Cell Lung Cancer for the Colombian Health System;Value in Health Regional Issues;2024-01

4. Diversity and Disparities in Lung Cancer Outcomes Among Minorities;The Cancer Journal;2023-11

5. Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer;Journal of Cancer Research and Therapeutics;2023